FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely surgical endocrinology. For prediction of efficiency of operative methods of primary hyperparathyroidism treatment at preoperative stage prognostic factor is calculated on the basis of level of parathyroid hormone, level of ionized calcium, level 25(OH)-vitamin D, mineral density of bone tissue, volume of changed parathyroid. If the prognostic coefficient is below 0.8106, high efficiency of minimally invasive interstitial laser photocoagulation under ultrasonic navigation is predicted. If the prognostic coefficient is 0.8106, or more, the high effectiveness of using the surgical management with single-stage removal of the parathyroid is predicted.
EFFECT: method enables preoperative predicting the effectiveness of surgical management by mathematical processing of significant indicators.
1 cl, 1 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PRIMARY AND SECONDARY HYPERPARATHYROIDISM | 2009 |
|
RU2392898C1 |
| METHOD OF DIAGNOSING PATHOLOGICALLY CHANGED PARATHYROID GLANDS | 2010 |
|
RU2432906C1 |
| DIFFERENTIAL TECHNIQUE FOR DIAGNOSTIC OF NECK FORMATIONS | 2014 |
|
RU2581521C2 |
| METHOD FOR NON-INVASIVE DIFFERENTIAL DIAGNOSIS OF PERIOCYTHOUS GREASES | 2021 |
|
RU2755931C1 |
| METHOD OF TREATING POSTOPERATIVE HYPOPARATHYROIDISM AFTER SURGERY IN PATIENTS WITH SECONDARY HYPERPARATHYROIDISM | 2023 |
|
RU2817205C1 |
| METHOD OF SURGICAL TREATMENT OF SECONDARY HYPERPARATHYROIDIS | 2022 |
|
RU2810945C2 |
| METHOD FOR PREOPERATIVE MARKING OF PATHOLOGICALLY CHANGED PARATHYROID GLANDS IN HYPERPARATHYROIDISM | 2024 |
|
RU2829683C1 |
| METHOD FOR THE DIFFERENTIAL DIAGNOSIS OF PARATHYROID GLAND LESIONS IN PRIMARY HYPERPARATHYROIDISM | 2022 |
|
RU2789012C1 |
| METHOD FOR PREDICTION OF HYPOCALCEMIA AFTER PARATHYROIDECTOMY IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM | 2022 |
|
RU2822014C2 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR SECONDARY AND TERTIARY HYPERPARATHYROID | 2013 |
|
RU2542456C1 |
